Literature DB >> 5884817

The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.

I A Jaffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5884817     DOI: 10.1002/art.1780080606

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  24 in total

1.  Penicillamine treatment of rheumatoid arthritis with a single daily dose of 250 mg.

Authors:  I A Jaffe
Journal:  Proc R Soc Med       Date:  1977

2.  Effect of penicillamine on the kidney.

Authors:  A M Davison; A T Day; J R Golding; D Thomson
Journal:  Proc R Soc Med       Date:  1977

3.  Gold or penicillamine?

Authors:  R C Offer
Journal:  Can Fam Physician       Date:  1981-02       Impact factor: 3.275

4.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Massive eosinophilia in rheumatoid arthritis: report of four cases.

Authors:  P T Dawes; D H Smith; D L Scott
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

6.  Amino acids and inflammation.

Authors:  G Thomas; G B West
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

7.  Drug-induced nephropathies.

Authors:  H C Burry
Journal:  Proc R Soc Med       Date:  1973-09

8.  Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.

Authors:  R Bluestone; R Grahame; V Holloway; P J Holt
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

9.  Observations on the treatment of rheumatoid disease with penicillamine.

Authors:  J R Golding; J V Wilson; A T Day
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

10.  The hand radiograph as a diagnostic discriminant between seropositive and seronegative 'rheumatoid arthritis': a controlled study.

Authors:  T M Burns; A Calin
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.